ArticleRadiology2016
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
2 registry-linked trialsOpen access · greenAbstract read
In one paragraph
Article in Radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 264 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
264citing papers in PubMed, 5 pooled it
44.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Use of PET/MR Radiomics to Evaluate the Clinical Phenotypes, Response Status of Neoadjuvant Chemotherapy and Long-term Prognosis of Breast Cancer: a Preliminary Study
Use of Imaging Markers by Fluorocholine PET/MR to Predict Molecular Subtypes and Clinical Outcomes of Breast Cancer: A Pilot Study
Who cites it
264 citing papers in PubMed, 5 syntheses or guidelines pooled it, 465 citations in OpenAlex.
- Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy.Seminars in cancer biology · 2022Pooled it
- What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies.International journal of molecular sciences · 2022Pooled it
- Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma.Alimentary pharmacology & therapeutics · 2021Pooled it
- Is radiomic MRI a feasible alternative to OncotypeDX® recurrence score testing? A systematic review and meta-analysis.BJS open · 2021Pooled it
- TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review.International journal of molecular sciences · 2019Pooled it
- Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learning.Thoracic cancer · 2022Trial
- Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.World journal of gastroenterology · 2022Trial
- A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer.Scientific reports · 2021Trial
- Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images.Scientific reports · 2021Trial
- Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluation.Abdominal radiology (New York) · 2019Trial
- Evaluating the Performance of Mammogram-Based AI Risk Model in Predicting Subsequent Breast Cancer in Women with a Prior History of Breast Cancer.Journal of clinical medicine · 2026Article
- Multiparametric MRI radiomics for noninvasive risk stratification of pediatric neuroblastoma: a pilot study.Scientific reports · 2026Article
- Predictions of Oncotype DXBioengineering (Basel, Switzerland) · 2026Article
- Deep interpretable radiogenomic workflow deciphers tumor microenvironment from breast MRI and identifies clinician-interpretable biomarkers.NPJ precision oncology · 2026Article
- Fréchet radiomic distance (FRD): A versatile metric for comparing medical imaging datasets.Medical image analysis · 2026Article
- Postmastectomy radiotherapy for early-stage breast cancer: can imaging bring us closer to personalized care?European radiology · 2026Article
- Mapping the Intratumoral and Peritumoral Microenvironment: Multilayered Shell ADC Analysis and Its Association with Multiparametric Biomarkers in Invasive Breast Cancer.Tomography (Ann Arbor, Mich.) · 2026Article
- Predicting hormone receptor status in tumors: An innovative approach using breast ultrasound-radiomics combined model.Medicine · 2026Article
- MRI-based texture analysis for breast cancer subtype classification in a multi-ethnic population.Magma (New York, N.Y.) · 2026Article
- K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy.Journal of applied clinical medical physics · 2026Article
204 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 7 institutions in 1 country.
Hui LiFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Yitan ZhuFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Elizabeth S BurnsideFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Karen DrukkerFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Katherine A HoadleyFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Cheng FanFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Suzanne D ConzenFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Gary J WhitmanFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Elizabeth J SuttonFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Jose M NetFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Marie GanottFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Erich HuangFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Elizabeth A MorrisFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Charles M PerouFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Yuan JiFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
Maryellen L GigerFrom the Depts of Radiology (H.L., K.D., M.L.G.) and Public Health Sciences (Y.J.), The Univ of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; Program of Computational Genomics & Medicine, NorthShore Univ HealthSystem, Evanston, Ill (Y.Z., Y.J.); Dept of Radiology, Univ of Wisconsin-Madison, Madison, Wis (E.S.B.); Lineberger Comprehensive Cancer Ctr, Univ of North Carolina, Chapel Hill, NC (K.A.H., C.F., C.M.P.); Dept of Medicine, Section of Hematology & Oncology, The Univ of Chicago, Chicago, Ill (S.D.C.); Dept of Diagnostic Radiology, The Univ of Texas MD Anderson Cancer Ctr, Houston, Tex (G.J.W.); Dept of Radiology, Memorial Sloan-Kettering Cancer Ctr, New York, NY (E.J.S., E.A.M.); Dept of Radiology, Univ of Miami Sylvester Comprehensive Cancer Ctr, Miami, Fla (J.M.N.); Dept of Radiology, Univ of Pittsburgh Medical Ctr, Pittsburgh, Pa (M.G.); and Div of Cancer Treatment and Diagnosis, National Cancer Inst, Biometric Research Branch, Bethesda, Md (E.H.).
University of Chicago · USUniversity of North Carolina at Chapel Hill · USMemorial Sloan Kettering Cancer Center · USNorthShore University HealthSystem · USSylvester Comprehensive Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Wisconsin–Madison · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MTumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8MUW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6MVIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1MTissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHARLES M PEROU · 1992 to 2026
$59.3MGene Expression Patterns in Human Tumors Identified Using Transcript SequencingU24CA143848 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAYES, DAVID N, PEROU, CHARLES M · 2009 to 2016
$20.8MTrainingU54AI117924 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI CRAVEN, MARK W. · 2014 to 2018
$11.3MLesion Composition and Quantitative Imaging Analysis on Breast Cancer DiagnosisR01CA166945 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GIGER, MARYELLEN L., SHEPHERD, JOHN ALAN · 2013 to 2017
$3.3MQuantitative Image Analysis for Assessing Response to Breast Cancer TherapyU01CA195564 · NCI · UNIVERSITY OF CHICAGO · PI GIGER, MARYELLEN L. · 2015 to 2019
$2.5MBayesian models for cancer prognosis by integrating diverse types of dataR01CA132897 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI JI, YUAN, MUELLER, PETER · 2008 to 2019
$2.1MMachine Learning for Improved Mammography ScreeningR01CA127379 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BURNSIDE, ELIZABETH S · 2007 to 2010
$1.4MMentoring And Research In Patient-Oriented Breast Cancer DiagnosisK24CA194251 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BURNSIDE, ELIZABETH S · 2015 to 2019
$963kNCI NIH HHS K24 CA194251NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA014520NCI NIH HHS P30 CA014599NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA058223NCI NIH HHS R01 CA127379NCI NIH HHS R01 CA132897NCI NIH HHS R01 CA166945NCI NIH HHS U01 CA195564NCI NIH HHS U24 CA143848NIAID NIH HHS U54 AI117924
Abstract
Purpose To investigate relationships between computer-extracted breast magnetic resonance (MR) imaging phenotypes with multigene assays of MammaPrint, Oncotype DX, and PAM50 to assess the role of radiomics in evaluating the risk of breast cancer recurrence. Materials and Methods Analysis was conducted on an institutional review board-approved retrospective data set of 84 deidentified, multi-institutional breast MR examinations from the National Cancer Institute Cancer Imaging Archive, along with clinical, histopathologic, and genomic data from The Cancer Genome Atlas. The data set of biopsy-proven invasive breast cancers included 74 (88%) ductal, eight (10%) lobular, and two (2%) mixed cancers. Of these, 73 (87%) were estrogen receptor positive, 67 (80%) were progesterone receptor positive, and 19 (23%) were human epidermal growth factor receptor 2 positive. For each case, computerized radiomics of the MR images yielded computer-extracted tumor phenotypes of size, shape, margin morphology, enhancement texture, and kinetic assessment. Regression and receiver operating characteristic analysis were conducted to assess the predictive ability of the MR radiomics features relative to the multigene assay classifications. Results Multiple linear regression analyses demonstrated significant associations (R
Indexed as
AdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsFemaleGene ExpressionGenomicsHumansImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMiddle AgedNeoplasm Recurrence, LocalPhenotypePredictive Value of TestsBiomarkers, Tumor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT05466760ClinicalTrials.gov
NCT07587086ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.